申请人:Wiley Robert Michael
公开号:US20050026928A1
公开(公告)日:2005-02-03
Compounds of formula (I)
in which R
1
, R
2
and X
4
have the meanings given in the specification are Factor Xa inhibitors useful in the treatment of thrombotic disorders.
式(I)中R1、R2和X4的含义如说明书所示的化合物是Xa因子抑制剂,可用于治疗血栓性疾病。